Serum viral interleukin-6 in AIDS-related multicentric Castleman disease.

Suppr

超能文献

作者信息

Aoki Y, Tosato G, Fonville T W, Pittaluga S

出版信息

Blood. 2001 Apr 15;97(8):2526-7. doi: 10.1182/blood.v97.8.2526.

DOI:10.1182/blood.v97.8.2526

PMID:11307774

Abstract

摘要

相似文献

Serum viral interleukin-6 in AIDS-related multicentric Castleman disease.

Blood. 2001 Apr 15;97(8):2526-7. doi: 10.1182/blood.v97.8.2526.

Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

Blood. 2001 Apr 1;97(7):2173-6. doi: 10.1182/blood.v97.7.2173.

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Blood. 2000 Sep 15;96(6):2069-73.

An attractive relation of human herpesvirus-8 with multicentric Castleman's disease.

Intern Med. 1999 Mar;38(3):221-2. doi: 10.2169/internalmedicine.38.221.

Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels.

Leuk Lymphoma. 2004 Sep;45(9):1939-41. doi: 10.1080/10428190410001693533.

HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever.

J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221097526. doi: 10.1177/23247096221097526.

Sustained high levels of serum HHV-8 DNA years before multicentric Castleman's disease despite full suppression of HIV with highly active antiretroviral therapy.

AIDS. 2003 Jun 13;17(9):1407-8. doi: 10.1097/00002030-200306130-00022.

Brief communication: rituximab in HIV-associated multicentric Castleman disease.

Ann Intern Med. 2007 Dec 18;147(12):836-9. doi: 10.7326/0003-4819-147-12-200712180-00003.

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

Blood. 2001 Apr 1;97(7):2130-6. doi: 10.1182/blood.v97.7.2130.

EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.

Int J Surg Pathol. 2018 Jun;26(4):338-341. doi: 10.1177/1066896917745584. Epub 2017 Dec 3.

引用本文的文献

Molecular Mechanisms of Kaposi Sarcoma-Associated Herpesvirus (HHV8)-Related Lymphomagenesis.

Cancers (Basel). 2024 Oct 31;16(21):3693. doi: 10.3390/cancers16213693.

HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.

Clin Microbiol Rev. 2024 Sep 12;37(3):e0002223. doi: 10.1128/cmr.00022-23. Epub 2024 Jun 20.

Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.

J Clin Oncol. 2022 Jan 20;40(3):294-306. doi: 10.1200/JCO.21.02040. Epub 2021 Dec 10.

Multicentric Castleman disease and the evolution of the concept.

Pathologica. 2021 Oct;113(5):339-353. doi: 10.32074/1591-951X-351.

Castleman disease.

Nat Rev Dis Primers. 2021 Nov 25;7(1):84. doi: 10.1038/s41572-021-00317-7.

Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.

Viruses. 2021 Sep 9;13(9):1797. doi: 10.3390/v13091797.

Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.

Blood Adv. 2021 Mar 23;5(6):1660-1670. doi: 10.1182/bloodadvances.2020004058.

Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Blood. 2020 Jun 18;135(25):2316-2319. doi: 10.1182/blood.2019004602.

Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.

J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.01555-19.

KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication.

PLoS Pathog. 2019 Dec 2;15(12):e1008185. doi: 10.1371/journal.ppat.1008185. eCollection 2019 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验